Company Name ORIG3N
Mailing Address 27 Drydock Ave. 6th Floor Boston, MA 02210 USA
Company Description Boston based ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology.
Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.